The treatment of allergic bronchopulmonary aspergillosis

descriptionPublicationkeyboard_double_arrow_right Article 01 Jan 2003 English Publisher:IMR PressJournal:Frontiers in Bioscience, volume 8, pages s243-245 (issn: 1093-9946, eissn: 1093-4715,

Copyright policy )

Authors: Asriani M, Chiu;

doi: 10.2741/965

pmid: 12700111

The treatment of allergic bronchopulmonary aspergillosis

- Summary
- Subjects
- Metrics

Abstract

Allergic bronchopulmonary aspergillosis (ABPA) is a disease characterized by asthma, peripheral eosinophilia, pulmonary infiltrates, hypersensitivity to Aspergillus fumigatus and bronchiectasis. The treatment of ABPA depends on the stage of the disease, and includes following clinical symptoms, serum IgE levels, pulmonary function tests, and chest radiographs. This review covers the current treatment options for ABPA.

Keywords

Aspergillosis, Allergic Bronchopulmonary, Humans

Impact byBIP!

	selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	1
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Average
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Average
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Average